Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06094491 · ClinicalTrials.gov registry record · Phase 2
Virtual Diabetes Group Visits Across Health Systems
A Phase 2 study of Obesity and Hypertension, sponsored by University of Chicago.
- Active
- Registry status
- Phase 2
- Development phase
- 720
- Enrollment target
- 2
- Study locations
NCT06094491 is a Phase 2 study of Obesity and Hypertension that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 720 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (12% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06094491, a Phase 2 study of Obesity and Hypertension, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 720 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
Conditions Studied
Interventions
- BEHAVIORAL Virtual Group Visit
Study Locations (2)
Illinois
- Access Community Health Network - Chicago
- Advocate Health Care - Orland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2024-05-03 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06094491
The ClinicalTrials.gov registry entry for NCT06094491 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (12% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Virtual Group Visit is the first listed.
NCT06094491 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06094491 about?
NCT06094491 is a clinical study titled "Virtual Diabetes Group Visits Across Health Systems". The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
What is the current status of trial NCT06094491?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 720 participants. The study started on 2024-05-03. Estimated completion is 2026-06-30.
What conditions does trial NCT06094491 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Stroke, Hyperlipidemias, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT06094491?
The interventions under investigation include: Virtual Group Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT06094491?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06094491 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.